Loss of muscle mass and physical functioning
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Born in Turkey, Morocco, or Surinam (or at least one of the parents was born there) - Aged >=55 years - Physical ability and willingness to execute an MCE program - Ability and willingness to comply with the study protocol - Written informed consent - Consent of the study physician (ability to comply with the protocol in the opinion of the study physician, to ensure safety for the participant) - Willingness that the GP will be notified on study participation
Exclusion criteria
Exclusion criteria: - Aged 3 - Phase IV cancer - Diagnosed degenerative neurocognitive disorders - Active (para-)medical treatment interfering with this intervention - Current enrolment in a fixed rehabilitation program or other intervention studies - Palliative treatment or a life expectancy of 2 weeks planned in first three months of study or >2 months during the rest of the intervention period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Physical functioning measured by the 6 minute walk test (6MWT) | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical functioning: • 30- seconds Chair Stand Test (30CST) • Single Leg Stance Test (SLST) Muscle strength and power: • Handgrip strength (handheld dynamometer (HGS)) • Lower extremity muscle strength (1-RM legpress and leg extension) • Lower extremity muscle strength (1-RM, Micro Force Evaluation and Testing (MicroFET)) Body composition/anthropometry: • Fat free mass, fat mass and total body water (Bodystat 1500 (BIA)) • Muscle quantity (2D ultrasound (2DUS)) • Body weight (calibrated weighing scale) • Height (cm from standing position) • Body Mass Index (BMI: kg/m2) Behavioral outcomes: • Dietary energy and protein intake (48-hr recall) • Physical activity (physical activity monitor (PAM)) Other outcomes: • Activities of Daily Lliving (Katz index (ADL)) • Frailty score (Rockwood) • Quality of Life (EQ-5D-5L and SarQoL questionnaires) • Feeling of depression and happiness (CES-D) • Pain, fear of falling, fatigue (Numeric rating scale, sFES-I) • Health care use and costs, out of pocket costs, productivity losses (MCQ +PCQ questionnaires) • Cost-effectiveness • Socio-demographic characteristics • Medical history • Adverse events • Adherence • Process evaluation | — |
Countries
Netherlands